sucralfate

FDA Drug Profile — sucralfate, Sucralfate oral suspension

sucralfate is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including sucralfate, Sucralfate oral suspension. Available dosage forms: suspension, tablet.

Drug details

Generic Name
sucralfate
Brand Names
sucralfate, Sucralfate oral suspension
Application Number
ANDA212913
Sponsor
Mylan Pharmaceuticals Inc.
NDC Codes
5
Dosage Forms
SUSPENSION, TABLET
Routes
ORAL
Active Ingredients
SUCRALFATE

Indications and Usage

INDICATIONS AND USAGE Sucralfate is indicated in: • Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. • Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.